Souhaitez-vous accéder aux communiqués récents ?

Eliminating positive foods identified by Biomerica’s diagnostic product showed statistically significant improvements (p<0.05) in both Quality of Life (FDA Instrument) and disease activity (Mayo...

Irvine, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,272,870 for the three months ending August 31, 2018, compared to $1,444,483 for the...

IRVINE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the fiscal year 2018 were $5,564,185...

Corporate Leaders from a Range of Industries to Present to 400+ Institutional Investors and Analysts SAN FRANCISCO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Liolios’ Gateway Conference is back for its...

IRVINE, Calif., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA) today announced that the Company has commenced clinical studies to evaluate the performance of its new and proprietary...

IRVINE, Calif. , Aug. 16, 2017 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) announced today a distribution agreement to supply one of its point of care products to a multinational...

IRVINE, CA--(Marketwired - May 23, 2017) - Biomerica Inc. (NASDAQ: BMRA) today announced it will present at the 18th Annual B. Riley institutional investor conference being held May 24-25, 2017 in...

IRVINE, CA--(Marketwired - April 17, 2017) - Biomerica, Inc. (NASDAQ: BMRA) today reported net sales of $4,342,247 for the nine months ending February 28, 2017, compared to $3,813,683 for the period...

IRVINE, CA--(Marketwired - March 09, 2017) - Biomerica Inc. (NASDAQ: BMRA) today announced it will present at the 29th Annual ROTH Conference being held March 12-15, 2017 in Dana Point, CA.Zackary...

Dublin, March 08, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Intellectual Property Attorney Hourly Rate Report 2017" report to their offering. The...